Skip to main content
SpringerLink
Log in

A proposal for a simplified MASCC score

  • Letter to the editor
  • Published:
Supportive Care in Cancer Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Klastersky J, Paesmans M, Rubenstein EB, Boyer M, Elting L, Feld R, Gallagher J, Herrstedt J, Rapoport B, Rolston K, Talcott J (2000) The Multinational Association for Supportive Care in Cancer risk index: a multinational scoring system for identifying low-risk febrile neutropenic cancer patients. J Clin Oncol 18:3038–3051

    PubMed  CAS  Google Scholar 

  2. Uys A, Rapoport BL, Anderson R (2004) Febrile neutropenia: a prospective study to validate the Multinational Association of Supportive Care of Cancer (MASCC) risk-index score. Support Care Cancer 8:556–560

    Google Scholar 

  3. Cherif H, Johansson E, Björkholm M, Kalin M (2006) The feasibility of early hospital discharge with oral antimicrobial therapy in low risk patients with febrile neutropenia following chemotherapy for hematologic malignancies. Haematologica 91:215–222

    PubMed  Google Scholar 

  4. Klastersky J, Ameye L, Maertens J, Georgala A, Muanza F, Aoun M, Ferrant A, Rapoport B, Rolston K, Paesmans M (2007) Bacteraemia in febrile neutropenic cancer patients. Int J Antimicrob Agents 30(Suppl 1):S51–S59

    Article  PubMed  CAS  Google Scholar 

  5. Uys A, Rapoport BL, Fickl H, Meyer PW, Anderson R (2007) Prediction of outcome in cancer patients with febrile neutropenia: comparison of the Multinational Association of Supportive Care in Cancer risk-index score with procalcitonin, C-reactive protein, serum amyloid A, and interleukins-1β, -6, -8 and -10. Eur J Cancer Care 16:475–483

    Article  CAS  Google Scholar 

  6. Girmenia C, Russo E, Carmosino I, Breccia M, Dragoni F, Latagliata R, Mecarocci S, Morano SG, Stefanizzi C, Alimena G (2007) Early hospital discharge with oral antimicrobial therapy in patients with hematologic malignancies and low-risk febrile neutropenia. Ann Hematol 86:263–270

    Article  PubMed  Google Scholar 

  7. de Souza VL, Serufo JC, da Costa Rocha MO, Costa RN, Duarte RC (2008) Performance of a modified MASCC index score for identifying low-risk febrile neutropenic cancer patients. Support Care Cancer 16:841–846

    Article  Google Scholar 

  8. Baskaran ND, Gan GG, Adeeba K (2008) Applying the Multinational Association for Supportive Care in Cancer risk scoring in predicting outcome of febrile neutropenia patients in a cohort of patients. Ann Hematol 87:563–569

    Article  PubMed  Google Scholar 

  9. Innes H, Lim SL, Hall A, Chan SY, Bhalla N, Marshall E (2008) Management of febrile neutropenia in solid tumours and lymphomas using the Multinational Association for Supportive Care in Cancer (MASCC) risk index: feasibility and safety in routine clinical practice. Support Care Cancer 16:485–491

    Article  PubMed  Google Scholar 

  10. Horasan ES, Ersoz G, Tombak A, Tiftik N, Kaya A (2011) Bloodstream infections and mortality-related factors in febrile neutropenic cancer patients. Med Sci Monit 17:CR304–CR309

    Article  PubMed  Google Scholar 

  11. Hui EP, Leung LK, Poon TC, Mo F, Chan VT, Ma AT, Poon A, Hui EK, Mak SS, Lai M, Lei KI, Ma BB, Mok TS, Yeo W, Zee BC, Chan AT (2011) Prediction of outcome in cancer patients with febrile neutropenia: a prospective validation of the Multinational Association for Supportive Care in Cancer risk index in a Chinese population and comparison with the Talcott model and artificial neural network. Support Care Cancer 19:1625–1635

    Article  PubMed  Google Scholar 

  12. Ahn S, Lee YS, Chun YH, Kwon IH, Kim W, Lim KS, Kim TW, Lee KH (2011) Predictive factors of poor prognosis in cancer patients with chemotherapy-induced febrile neutropenia. Support Care Cancer 19:1151–1158

    Article  PubMed  Google Scholar 

  13. de Naurois J, Novitzky-Basso I, Gill MJ, Marti Marti F, Cullen MH, Roila F, ESMO Guidelines Working Group (2010) Management of febrile neutropenia: ESMO Clinical Practice Guidelines. Ann Oncol 21(Suppl 5):v252–v256

    Article  PubMed  Google Scholar 

  14. Worth LJ, Lingaratnam S, Taylor A, Hayward AM, Morrissey S, Cooney J, Bastick PA, Eek RW, Wei A, Thursky KA, Australian Concensus Guidelines 2011 Steering Committee (2011) Use of risk stratification to guide ambulatory management of neutropenic fever. Australian Concensus Guidelines 2011 Steering Committee. Intern Med J 41:82–89

    Article  PubMed  CAS  Google Scholar 

  15. Freifeld AG, Bow EJ, Sepkowitz KA, Boeckh MJ, Ito JI, Mullen CA, Raad II, Rolston KV, Young JH, Wingard JR (2011) Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of America. Clin Infect Dis 52(4):e56–e93

    Article  PubMed  Google Scholar 

  16. Tam CS, O'Reilly M, Andresen D, Lingaratnam S, Kelly A, Burbury K, Turnidge J, Slavin MA, Worth LJ, Dawson L, Thursky KA (2011) Use of empiric antimicrobial therapy in neutropenic fever. Australian Consensus Guidelines 2011 Steering Committee. Intern Med J 41:90–101

    Article  PubMed  CAS  Google Scholar 

  17. Cheung M (2012) Febrile Neutropenia | MASCC. QxMD Software. http://www.qxmd.com/calculate-online/hematology/febrile-neutropenia-mascc. Accessed 28 Feb 2012

  18. Davis DA, Taylor-Vaisey A (1997) Translating guidelines into practice. A systematic review of theoretic concepts, practical experience and research evidence in the adoption of clinical practice guidelines. CMAJ 157:408–416

    PubMed  CAS  Google Scholar 

  19. Livesey EA, Noon JM (2007) Implementing guidelines: what works. Arch Dis Child Educ Pract Ed 92:129–134

    Article  Google Scholar 

Download references

Conflict of interest

None.

Author information

Authors and Affiliations

  1. Erasmus Medical Centre, Rotterdam, The Netherlands

    Jasmijn C. A. Wierema

  2. St George Cancer Centre and University of New South Wales Clinical School, Gray St Kogarah, Sydney, NSW, 2217, Australia

    Matthew Links

Authors
  1. Jasmijn C. A. Wierema
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Matthew Links.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wierema, J.C.A., Links, M. A proposal for a simplified MASCC score. Support Care Cancer 21, 915–916 (2013). https://doi.org/10.1007/s00520-012-1676-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00520-012-1676-4

Keywords

Search

Navigation